ArticleImmunologic research2024

Changes in immune subsets during chemotherapy as prognosis biomarkers for multiple myeloma patients by longitudinal monitoring.

Pengcheng Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.